Salmonella Conjugates CVD 2000: Study of Responses to Vaccination With Trivalent Salmonella Conjugate Vaccine to Prevent Invasive Salmonella Disease

Condition:   Risk Reduction Interventions:   Biological: Trivalent Salmonella Conjugate Vaccine (TSCV) Full-Strength Formulation;   Biological: Trivalent Salmonella Conjugate Vaccine (TSCV) Half-Strength Formulation;   Biological: Trivalent Salmonella Conjugate Vaccine (TSCV) Dilutional Half-Strength Formulation;   Other: Placebo Sponsor:   University of Maryland, Baltimore Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials